Abstract
Atypical teratoid/rhabdoid tumor (AT/RT) is a highly malignant tumor of the central nervous system characterized by biallelic inactivation of SWI/SNF chromatin remodeling complex members SMARCB1/ INI1 or (rarely) SMARCA4/BRG1. Most high-grade central nervous system lesions showing loss of nuclear SMARCB1 or SMARCA4 protein expression can indeed be categorized as AT/RT. However, some high-grade lesions have been identified, whose clinical and/or molecular features justify separation from AT/RT. Furthermore, other recently described tumor types such as desmoplastic myxoid tumor, SMARCB1-mutant, and low-grade diffusely infiltrative tumor, SMARCB1-mutant, may even manifest as low-grade lesions. Here, we review recent developments in the definition of the molecular landscape of AT/RT and give an update on other rare high- and low-grade SWI/SNF-deficient central nervous system tumors.
Original language | English |
---|---|
Pages (from-to) | 2-9 |
Number of pages | 8 |
Journal | Clinical Neuropathology |
Volume | 43 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2024 |
Keywords
- DNA methylation profiling
- malignant rhabdoid tumor
- neuropathology
- SMARCA4
- SMARCB1